Tyra Biosciences, Inc.
Asset & Liabilities Breakdown
Asset Breakdown FY2023
Total Assets: $225.9M
Liabilities Breakdown FY2023
Total Liabilities: $21.6M
Asset Breakdown
Total Assets: $225.9M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $58.0M | 25.7% |
| Accounts Receivable | $0 | 0.0% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $1.6M | 0.7% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $166.2M | 73.6% |
Liabilities Breakdown
Total Liabilities: $21.6M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $4.7M | 21.6% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $16.9M | 78.4% |